Files
Document type
ArticleVersion
Published versionPublication date
Publication license
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/105635
Stratification and therapeutic potential of PML in metastatic breast cancer
Journal Title
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
Patient stratification has been instrumental for the success of targeted therapies in breast cancer. However, the molecular basis of metastatic breast cancer and its therapeutic vulnerabilities remain poorly understood. Here we show that PML is a novel target in aggressive breast cancer. The acquisition of aggressiveness and metastatic features in breast tumours is accompanied by the elevated PML expression and enhanced sensitivity to its inhibition. Interestingly, we find that STAT3 is responsible, at least in part, for the transcriptional upregulation of PML in breast cancer. Moreover, PML targeting hampers breast cancer initiation and metastatic seeding. Mechanistically, this biological activity relies on the regulation of the stem cell gene SOX9 through interaction of PML with its promoter region. Altogether, we identify a novel pathway sustaining breast cancer aggressiveness that can be therapeutically exploited in combination with PML-based stratification.
Subject
Subject (English)
Citation
Citation
MARTÍN-MARTÍN, Natalia, et al. Stratification and therapeutic potential of PML in metastatic breast cancer. Nature Communications. 2016. Vol. 7, num. 12595. ISSN 2041-1723. [consulted: 9 of June of 2026]. Available at: https://hdl.handle.net/2445/105635